Deltorphin I

From WikiMD's WELLNESSPEDIA

Chemical structure of Deltorphin I

Deltorphin I is a naturally occurring opioid peptide that is known for its high affinity and selectivity for the delta-opioid receptor. It is one of the most potent delta-opioid receptor agonists discovered in nature. Deltorphin I was originally isolated from the skin of frogs belonging to the genus Phyllomedusa, specifically Phyllomedusa bicolor.

Structure[edit]

Deltorphin I is a heptapeptide with the amino acid sequence Tyr-D-Ala-Phe-Asp-Val-Val-Gly-NH2. The presence of D-amino acids in its structure is crucial for its high affinity and selectivity towards the delta-opioid receptor. The peptide's structure allows it to interact effectively with the receptor, leading to its potent analgesic effects.

Mechanism of Action[edit]

Deltorphin I exerts its effects by binding to the delta-opioid receptor, a type of G protein-coupled receptor (GPCR) found in the central nervous system. Upon binding, it activates the receptor, leading to a cascade of intracellular events that result in analgesia. The activation of delta-opioid receptors by Deltorphin I can modulate neurotransmitter release and influence pain perception.

Pharmacological Effects[edit]

The primary effect of Deltorphin I is analgesia, making it a subject of interest for pain management research. Unlike mu-opioid receptor agonists, delta-opioid receptor agonists like Deltorphin I may produce analgesia with a lower risk of addiction and respiratory depression. However, the clinical application of Deltorphin I is limited due to its peptide nature, which affects its stability and bioavailability.

Sources and Isolation[edit]

Deltorphin I was first isolated from the skin secretions of Phyllomedusa bicolor, a frog native to South America. The isolation of Deltorphin I and related peptides has provided insights into the diversity of bioactive compounds in amphibian skin and their potential therapeutic applications.

Research and Applications[edit]

Research on Deltorphin I focuses on its potential use in pain management and its role in understanding the delta-opioid receptor system. Studies aim to develop analogs with improved stability and bioavailability for potential therapeutic use. Additionally, Deltorphin I serves as a tool in pharmacological research to study the delta-opioid receptor and its physiological roles.

Related Pages[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.